Skip to content

Author

Carlos E. Costa

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Sep 2026

CRISPR-Cas9 engineering for high-level β-galactosidase production in Saccharomyces boulardii.

A validated CRISPR-Cas9 strategy for high extracellular β-galactosidase secretion in the clinically established S. boulardii CNCM I-745 is demonstrated, providing a foundation for future studies where the potential of the developed strains is evaluated in clinically relevant settings.

J. Carvalho, David Sáez Moreno, Carlos E. Costa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.